Reduced TH expression and α-synuclein accumulation contribute towards nigrostriatal dysfunction in experimental hepatic encephalopathy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Restorative Neurology and Neuroscience

• Publication date

  2017-10-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3233/RNN-170728PMID 28984618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Environment-contact administration of rotenone: A new rodent model of Parkinson's disease.

  2015cited by this paper
• The nuclear accumulation of alpha-synuclein is mediated by importin alpha and promotes neurotoxicity by accelerating the cell cycle.

  2014cited by this paper
• Nuclear translocation of alpha-synuclein increases susceptibility of MES23.5 cells to oxidative stress.

  2013cited by this paper
• α-Synuclein Elevation in Human Neurodegenerative Diseases: Experimental, Pathogenetic, and Therapeutic Implications

  2012cited by this paper
• Significant Volume Reduction and Shape Abnormalities of the Basal Ganglia in Cases of Chronic Liver Cirrhosis

  2012cited by this paper
• Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons

  2011cited by this paper
• α-Synuclein overexpression impairs mitochondrial function by associating with adenylate translocator.

  2011cited by this paper
• Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria.

  2011cited by this paper
• Alpha-synuclein functions as a negative regulator for expression of tyrosine hydroxylase.

  2011cited by this paper
• A53T-alpha-synuclein-overexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAP

  2011cited by this paper
• Neuronal activity regulates expression of tyrosine hydroxylase in adult mouse substantia nigra pars compacta neurons

  2011cited by this paper
• Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice

  2010cited by this paper
• Stimulated dopamine overflow and alpha‐synuclein expression in the nucleus accumbens core distinguish rats bred for differential ethanol preference

  2010cited by this paper
• Serine 129 Phosphorylation Reduces the Ability of α-Synuclein to Regulate Tyrosine Hydroxylase and Protein Phosphatase 2A in Vitro and in Vivo

  2010cited by this paper
• Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies*

  2010cited by this paper
• GFAP reactivity, apolipoprotein E redistribution and cholesterol reduction in human astrocytes treated with alpha-synuclein.

  2010cited by this paper
• Proteinase K-resistant α-synuclein is deposited in presynapses in human Lewy body disease and A53T α-synuclein transgenic mice

  2010cited by this paper
• Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease.

  2010cited by this paper
• Ammonium chloride and tunicamycin are novel toxins for dopaminergic neurons and induce Parkinson’s disease‐like phenotypes in medaka fish

  2010influential reference
• Neuroinflammation in Parkinson's disease: a target for neuroprotection?

  2009cited by this paper
• A chemical neurotoxin, MPTP induces Parkinson's disease like phenotype, movement disorders and persistent loss of dopamine neurons in medaka fish.

  2009cited by this paper
• Experimental models of hepatic encephalopathy: ISHEN guidelines

  2009cited by this paper
• Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice.

  2008cited by this paper
• Origins and effects of extracellular alpha-synuclein: implications in Parkinson's disease.

  2008cited by this paper
• Origins and Effects of Extracellular α-synuclein: Implications in Parkinson’s Disease

  2007cited by this paper
• The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates

  2007cited by this paper
• Presynaptic α-Synuclein Aggregates, Not Lewy Bodies, Cause Neurodegeneration in Dementia with Lewy Bodies

  2007cited by this paper
• Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson’s disease

  2007cited by this paper
• Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease.

  2007cited by this paper
• Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.

  2007cited by this paper
• Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra.

  2006cited by this paper
• Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity.

  2006cited by this paper
• Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype

  2006cited by this paper
• Brain edema and inflammatory activation in bile duct ligated rats with diet‐induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis

  2006cited by this paper
• Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson’s disease: a case for the selective vulnerability of the substantia nigra

  2006cited by this paper
• Oxidative stress induces nuclear translocation of C-terminus of alpha-synuclein in dopaminergic cells.

  2006cited by this paper
• Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates

  2005cited by this paper
• α-Synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells

  2005cited by this paper
• Alpha‐synuclein dysfunction in Lewy body diseases

  2005cited by this paper
• DOPAMINE CELL MORPHOLOGY AND GLIAL CELL HYPERTROPHY AND PROCESS BRANCHING IN THE NIGROSTRIATAL SYSTEM AFTER STRIATAL 6-OHDA ANALYZED BY SPECIFIC STEROLOGICAL TOOLS

  2005cited by this paper
• Alpha-synuclein immunoreactivity in neuronal nuclear inclusions and neurites in multiple system atrophy.

  2004cited by this paper
• Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?

  2004cited by this paper
• Does α‐synuclein modulate dopaminergic synaptic content and tone at the synapse?

  2004cited by this paper
• Overexpression of α‐synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of α‐synuclein and activation of caspase‐9: resemblance to pathogenetic changes in Parkinson's disease

  2004cited by this paper
• α-Synuclein immunoreactivity in neuronal nuclear inclusions and neurites in multiple system atrophy

  2004cited by this paper
• α-Synuclein aggregation and neurodegenerative diseases

  2003cited by this paper
• Nuclear Localization of α-Synuclein and Its Interaction with Histones†

  2003cited by this paper
• Molecular Pathways of Neurodegeneration in Parkinson's Disease

  2003cited by this paper
• Correlation between ammonia levels and the severity of hepatic encephalopathy.

  2003cited by this paper
• Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration.

  2003cited by this paper
• The Role of Glial Reaction and Inflammation in Parkinson's Disease

  2003cited by this paper
• Pathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies.

  2003cited by this paper
• Alpha-synuclein aggregation and neurodegenerative diseases.

  2003cited by this paper
• Chronic Parkinsonism Associated With Cirrhosis

  2003cited by this paper
• Nuclear localization of alpha-synuclein and its interaction with histones.

  2003cited by this paper
• The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein.

  2002cited by this paper
• A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis

  2002cited by this paper
• alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.

  2002cited by this paper
• A role for alpha-synuclein in the regulation of dopamine biosynthesis.

  2002cited by this paper
• The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice

  2002cited by this paper
• α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease

  2002cited by this paper
• Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture.

  2002cited by this paper
• Clinical Significance of Basal Ganglia Alterations at Brain MRI and 1H MRS in Cirrhosis and Role in the Pathogenesis of Hepatic Encephalopathy

  2002cited by this paper
• Heterogeneity of nigral and cortical Lewy bodies differentiated by amplified triple-labeling for alpha-synuclein, ubiquitin, and thiazin red.

  2002cited by this paper
• Astroglial and Microglial Reaction After A Partial Nigrostriatal Degeneration Induced by The Striatal Injection of Different Doses of 6-Hydroxydopamine

  2001cited by this paper
• Glial cell death induced by overexpression of α‐synuclein

  2001cited by this paper
• Glial cell death induced by overexpression of alpha-synuclein.

  2001cited by this paper
• Movement Dysfunction and Hepatic Encephalopathy

  2001cited by this paper
• Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis.

  2000cited by this paper
• NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson’s disease brains

  2000cited by this paper
• NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains.

  2000cited by this paper
• Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

  2000cited by this paper
• Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.

  2000cited by this paper
• α-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining

  2000cited by this paper
• α‐Synuclein Up‐Regulation in Substantia Nigra Dopaminergic Neurons Following Administration of the Parkinsonian Toxin MPTP

  2000cited by this paper
• The role of astrocytes in the development of hepatic encephalopathy.

  1999cited by this paper
• Invited Review: Repair in Goldfish Central Nervous System.

  1998cited by this paper
• The Basal Ganglia and Portal-Systemic Encephalopathy

  1998cited by this paper
• Changes in Glial Fibrillary Acidic Protein Immunoreactivity in Response to Experimental Hepatic Encephalopathy in the Rat Hippocampus

  1998cited by this paper
• Astroglial Dysfunction in Hepatic Encephalopathy

  1998cited by this paper
• α-Synuclein in Lewy bodies

  1997cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• A low-protein diet ameliorates disrupted diurnal locomotor activity in rats after portacaval anastomosis.

  1996cited by this paper
• Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity.

  1991cited by this paper
• Discordant motor activity levels of portacaval-shunted rats in runway and swim tests.

  1986cited by this paper

• Beyond Organ Boundaries: Molecular Mechanisms of Hepatic Encephalopathy and Parkinson’s Disease from the Perspective of the Gut–Liver–Brain Axis

  2025cites this paper
• Early expression of monomeric and oligomeric alpha-synuclein and reduction of tyrosine hydroxylase following intranigral injection of lipopolysaccharide

  2024cites this paper
• Bile duct ligation increased dopamine levels in the cerebral cortex of rats partly due to induction of tyrosine hydroxylase

  2023cites this paper